Change from baseline in (A) E-RS total score and (B) E-RS cough and sputum domain score over the study period in ATTAIN and the active-comparator study.

Slides:



Advertisements
Similar presentations
Vitamin D3 increased ASL antimicrobial activity.
Advertisements

Least squares (LS) mean change from baseline (95% CI) in St George's Respiratory Questionnaire (SGRQ) Total score according to previous chronic obstructive.
Flow diagram of participants included in the survey. aResponse rate
The significantly different metabolites between the systemic inflammatory response syndrome SIRS (n=15) and sepsis (n=35) groups (A); the sepsis (n=10)
Least squares (LS) mean change from baseline (95% CI) in trough forced expiratory volume in 1 s (FEV1) according to chronic obstructive pulmonary disease.
Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.
Image of the form used by ambulance officers to triage patients with an exacerbation of chronic obstructive pulmonary disease (COPD).  GP, general practitioner;
Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.
Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3. Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3.
Least squares (LS) mean change from baseline (95% CI) in St George's Respiratory Questionnaire (SGRQ) Total score according to exacerbation history (intent-to-treat.
Monthly admissions for chronic obstructive pulmonary disease (COPD) to Christchurch Hospital. Monthly admissions for chronic obstructive pulmonary disease.
The top 25 analytes by relevant q-value differentially expressed in HIV with COPD. The top number is m/z and the bottom number is RT. Y-axis is intensity.
Effects of reslizumab on asthma quality of life questionnaire (AQLQ) score in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of reslizumab.
Association of sputum colour score with (A) total cell counts; (B) neutrophil proportion; (C) neutrophil number and (D) CXCL-8 concentration. Association.
Serum levels of angiopoietin-like protein 4 (ANGPTL4) according to patients with chronic obstructive pulmonary disease and controls without any lung disease.
Effects of reslizumab on asthma control questionnaire-7 (ACQ-7) score in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of reslizumab.
A white elephant or the elephant in the room
Comparison of the age-associated prevalence (y axis) in the Catalan Healthcare Surveillance System (CHSS) and Medicare datasets of selected disease groups.
Change from baseline in the severity of night-time cough and the frequency of night-time sputum production at week 12 in ACCORD COPD I.17 Data are reported.
Least squares (LS) mean change from baseline (95% CI) in St George's Respiratory Questionnaire (SGRQ) Total score according to chronic obstructive pulmonary.
Prevalence (x axis) of disease groups (DGs) (y axis) in the population of Medicare (light cyan) and Catalan Healthcare Surveillance System (CHSS) (light.
(A) Temporal order of pairwise diagnoses in patients with chronic obstructive pulmonary disease (COPD). (A) Temporal order of pairwise diagnoses in patients.
Patients’ pathways to Accident and Emergency (A&E)
Least squares (LS) mean change from baseline (95% CI) in trough forced expiratory volume in 1 s (FEV1) according to exacerbation history (intent-to-treat.
Incidence of choking in London, UK, by gender per 1000 population by age group. Incidence of choking in London, UK, by gender per 1000 population by age.
Peripheral blood eosinophil levels based on a threshold of (A) 150 cells/μL, patients not randomised to inhaled corticosteroids (ICS)-containing treatment.
Use of medication among chronic obstructive pulmonary disease (COPD) cases by age and place of residence among 1586 COPD cases. The dark grey bar represents.
a) Mortality per time point (p<0
Change from baseline in the severity of morning cough and severity of difficulty bringing up phlegm in the morning over the study period in the active-comparator.
Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by age, and place of residence. The dark grey bar represents ‘rural’
Accuracy of sputum colour in predicting NB
Forest plots for randomised and cluster randomised controlled trials from Cochrane review Biomarkers as point-of-care tests to guide prescription of antibiotics.
Comparison of the serum levels of the three vascular endothelial growth factor (VEGF) types in healthy volunteers and patients with idiopathic pulmonary.
Kaplan–Meier curves for the time until myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-positive conversion (A: MPO-ANCA, B: proteinase 3.
Receiver under the operator characteristic (ROC) curve for the test accuracy of the final risk score in the entire external validation sample (c statistic=0.84,
Changes in median exhaled CO levels from baseline to 12 weeks in quitters (n=183) and continuous smokers (n=94). Changes in median exhaled CO levels from.
Changes in St. George's Respiratory Questionnaire (SGRQ) scores from baseline to 12 weeks for total samples (n=277), quitters (n=183) and continuous smokers.
Slope of FEV1 by age at enzyme replacement therapy (ERT) initiation FEV1 z-score slope (y-axis) by age categorised in three groups (red, ERT initiation 
Comparative receiver operating characteristic (ROC) curves and the area under the curve (AUC) in association with 30-day mortality for severity scores.
Receiver operating characteristic curves (ROC) for the metabolites between the systemic inflammatory response syndrome (n=15) and sepsis (n=35) groups.
SGRQ total scores by (A) FVC % predicted at baseline and (B) use of supplemental oxygen at baseline. SGRQ total scores by (A) FVC % predicted at baseline.
Pattern recognition analyses of serum liquid chromatography–mass spectrometry (LC-MS/MS) spectra. Pattern recognition analyses of serum liquid chromatography–mass.
Worse eDiary scores are associated the more rescue inhaler usage and reduced step counts over both an individual day and 3-week summary period. Worse eDiary.
Manhattan plot for the association between COPD and DNA methylation in never smokers (left) and current smokers (right). Manhattan plot for the association.
Changes in 6 min walk distance (6MWD) for combined pulmonary fibrosis and emphysema (CPFE) (n=15), and chronic obstructive pulmonary disease (COPD) (n=37).
(A) Energy and (B) protein intake/day during hospitalisation and in follow-up. (A) Energy and (B) protein intake/day during hospitalisation and in follow-up.
Stepwise management. Stepwise management. Antibiotics are used to treat exacerbations that present with an acute detrioration (usually over several days)
All microorganism strains isolated from the sputum during the study period. All microorganism strains isolated from the sputum during the study period.
Screening test accuracy of the final risk score at a threshold of ≥2
Distribution of patients in the first- or second-year follow-up according to the number of acute exacerbations of chronic obstructive pulmonary disease.
Plots showing baseline correlation between the modified Medical Research Council (mMRC) dyspnoea scale, Baseline Dyspnoea Index (BDI), COPD Assessment.
Reclined functional residual capacity (FRC) predicts cough inspired volume, which in turn predicts cough flow. Reclined functional residual capacity (FRC)
HFNC off is compared with HFNC 30 L/min and HFNC 50 L/min for tidal volume. HFNC off is compared with HFNC 30 L/min and HFNC 50 L/min for tidal volume.
Weekly bronchitis cases (circles, left hand axis) and particulate matter with a diameter below 10 µ (PM10) (crosses, right hand axis), with smoothed curves.
COPD Action Plan adherence.
The telesystem. The telesystem. Patients received regular automated calls from a computer-linked telesystem. Patients could also directly contact the telesystem.
In-room sound levels recorded by sound metres on decibels on the A-weighted (dBA) and decibels on the C-weighted scale (dBC) scales. In-room sound levels.
Vitamin D3 increased ASL antimicrobial activity in non-smokers.
Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by region. The dark grey bar represents ‘symptom-based COPD’,
Mean (95% CI) change in Clinical COPD Questionnaire (CCQ) with pulmonary rehabilitation, according to achievement (+) or non-achievement (−) of the established.
Accuracy of sputum colour in predicting neutrophilic inflammation.
Scatterplots showing baseline correlation between forced expiratory volume in 1 s (FEV1) % pred and a) COPD Assessment Test (CAT), b) Clinical COPD Questionnaire.
Directed acyclic graph showing potential confounders of the association between maternal total iron status in pregnancy (exposure of interest) and offspring.
Odds ratio (95% confidence intervals) of reporting respiratory symptoms in patients with treated hypothyroidism or inflammatory bowel disease (IBD) compared.
Effects of reslizumab on lung function (forced expiratory volume in 1 s; FEV1) in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of.
ICU length of stay comparing LTV and HTV mechanical ventilation in adult patients with ARDS. ARDS, acute respiratory distress syndrome; HTV, higher tidal.
Stacked bar charts for key predictor variables (representativeness of SLS COPD). Stacked bar charts for key predictor variables (representativeness of.
Frequency distribution histograms of the Exacerbations of Chronic Pulmonary Disease Tool (EXACT) total, the COPD Assessment Test (CAT), the St George’s.
Receiver operating characteristic (ROC) curves for Saint George’s Respiratory Questionnaire (SGRQ) category scores predicting chronic obstructive pulmonary.
Change in COPD (chronic obstructive pulmonary disease) assessment test (CAT) score after pulmonary rehabilitation corresponding to different responses.
Presentation transcript:

Change from baseline in (A) E-RS total score and (B) E-RS cough and sputum domain score over the study period in ATTAIN and the active-comparator study. Change from baseline in (A) E-RS total score and (B) E-RS cough and sputum domain score over the study period in ATTAIN and the active-comparator study. Data are reported as LS mean+SE. E-RS total score ranged from 0 to 40; E-RS cough and sputum domain score ranged from 0 to 11. Higher scores indicate more severe symptoms. *p<0.05, **p<0.01, ***p<0.001 vs placebo. E-RS, Evaluating Respiratory Symptoms, formerly known as EXAcerbations of Chronic pulmonary disease Tool; LS, least squares; MCID, minimum clinically important difference. Lorcan McGarvey et al. BMJ Open Resp Res 2016;3:e000148 ©2016 by British Thoracic Society